Sigyn Therapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

EARNINGS PER SHARE

EARNINGS PER SHARE

12 Months Ended

Dec. 31, 2018

NOTE 14 – EARNINGS PER SHARE

FASB ASC Topic 260, Earnings Per Share, requires a reconciliation of the numerator and denominator of the basic and diluted earnings (loss) per share (EPS) computations.

Basic earnings (loss) per share are computed by dividing net earnings available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. In periods where losses are reported, the weighted-average number of common stock outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive.

Basic and diluted earnings (loss) per share are the same since net losses for all periods presented and including the additional potential common shares would have an anti-dilutive effect.

The following table sets forth the computation of basic and diluted net income per share:

	For the Years Ended December 31,
	2018			2017

Loss from continuing operations	$	(2,305,277	)	$	(3,845,297	)
Discontinued operations		(314,997	)		(405,967	)
Net loss attributable to the common stockholders	$	(2,620,274	)	$	(4,251,264	)

Basic weighted average outstanding shares of common stock		65,069,763			47,093,401
Dilutive effect of options and warrants		—			—
Diluted weighted average common stock and common stock equivalents		65,069,763			47,093,401

Loss per share:
Net loss per share from continuing operations, basic and diluted	$	(0.04	)	$	(0.08	)
Net loss per share from discontinued operations, basic and diluted		(0.00	)		(0.01	)
Net loss per share total, basic and diluted	$	(0.04	)	$	(0.09	)